Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.

Published Date: 16 Aug 2023

Most cancer deaths result from the metastatic spread and expansion of tumor cells at distant sites. Because there are few biomarkers and detection methods, it is difficult to determine the best treatments for patients with metastatic disease.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mobile prostate cancer screening clinic can ID the disease in disadvantaged men

2.

Through Consolidation Durvalumab, Limited-Stage SCLC Receives a New Standard of Care.

3.

Durvalumab Wins FDA Approval in Limited-Stage SCLC

4.

investigating radiation oncology applications of artificial general intelligence.

5.

Global warming could be driving up women's cancer risk, find researchers


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot